Search Results - "Spijker, Henri"
-
1
Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody–Drug Conjugate SYD985
Published in Molecular pharmaceutics (01-06-2015)“…Antibody–drug conjugates (ADCs) that are currently on the market or in clinical trials are predominantly based on two drug classes: auristatins and…”
Get full text
Journal Article -
2
Preclinical profile of the HER2-targeting ADC SYD983/SYD985: introduction of a new duocarmycin-based linker-drug platform
Published in Molecular cancer therapeutics (01-11-2014)“…A linker-drug platform was built on the basis of a cleavable linker-duocarmycin payload for the development of new-generation antibody-drug conjugates (ADC). A…”
Get full text
Journal Article -
3
A Platform for the Generation of Site-Specific Antibody–Drug Conjugates That Allows for Selective Reduction of Engineered Cysteines
Published in Bioconjugate chemistry (16-09-2020)“…Engineering cysteines at specific sites in antibodies to create well-defined ADCs for the treatment of cancer is a promising approach to increase the…”
Get full text
Journal Article -
4
Atom Transfer Radical Polymerization of Adenine, Thymine, Cytosine, and Guanine Nucleobase Monomers
Published in Macromolecules (09-01-2007)“…Methacrylate monomers functionalized with thymine, adenine, cytosine, and guanine were prepared by alkylation of the nucleobases with 3-bromopropyl…”
Get full text
Journal Article -
5
Synthesis and assembly behavior of nucleobase-functionalized block copolymers
Published in Journal of polymer science. Part A, Polymer chemistry (01-07-2006)“…Block copolymers consisting of a poly(ethylene glycol) chain and a thymine‐ or adenine‐functional polymethacrylate block have been prepared with atom transfer…”
Get full text
Journal Article -
6
Abstract 4640: Development of antibody-drug conjugate technology based on novel DNA-interacting agents and unique linker technology
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Abstract Antibody-Drug Conjugation (ADC) is gaining momentum as a next generation antibody therapeutics approach in oncology. Tumor specific delivery of the…”
Get full text
Journal Article -
7
Abstract 4397: Development of antibody-drug conjugate technology based on novel linkers & DNA alkylating duocarmycin derivatives
Published in Cancer research (Chicago, Ill.) (15-04-2010)“…Abstract Antibody-Drug Conjugation (ADC) is gaining momentum as a next generation antibody therapeutics approach in oncology. Tumor specific delivery of the…”
Get full text
Journal Article -
8
Unusual rate enhancement in the thymine assisted ATRP process of adenine monomers
Published in Polymer (Guilford) (08-09-2005)“…Thymine and adenine monomers were synthesized and polymerized using ATRP in a controlled fashion. In addition a thymine functionalized block copolymer was…”
Get full text
Journal Article -
9